Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion type Assertion NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_head.
- NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion description "[The safety and efficacy of targeting B7-H3 with a monoclonal antibody for the treatment of advanced-stage central nervous system cancer in children has been proven, making B7-H3 an attractive therapeutic target for this kind of tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_provenance.
- NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion evidence source_evidence_literature NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_provenance.
- NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion SIO_000772 24013874 NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_provenance.
- NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion wasDerivedFrom befree-20150227 NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_provenance.
- NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_assertion wasGeneratedBy ECO_0000203 NP949696.RA2n5aEJUca_B3Iw4M4LB4BwhGJ6B5DuKHmffoMRL726s130_provenance.